<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1729-519X</journal-id>
<journal-title><![CDATA[Revista Habanera de Ciencias Médicas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev haban cienc méd]]></abbrev-journal-title>
<issn>1729-519X</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas de la Habana]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1729-519X2022000100015</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Análisis de riesgo en la terapia paciente específica del hipertiroidismo en Cuba]]></article-title>
<article-title xml:lang="en"><![CDATA[Risk analysis in patient-specific therapy for hyperthyroidism in Cuba]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Amador Balbona]]></surname>
<given-names><![CDATA[Zayda Haydée]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Torres Valle]]></surname>
<given-names><![CDATA[Antonio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López Díaz]]></surname>
<given-names><![CDATA[Adlin]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro de Isótopos  ]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de La Habana Facultad de Tecnologías y Ciencias Aplicadas ]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2022</year>
</pub-date>
<volume>21</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1729-519X2022000100015&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1729-519X2022000100015&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1729-519X2022000100015&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: En Cuba, se prevé realizar la terapia paciente específica del hipertiroidismo. Se han desarrollado una metodología y herramientas computacionales con este propósito. El análisis del riesgo permitirá acometer con calidad y seguridad dicha práctica.  Objetivo: Analizar los riesgos radiológicos en la terapia paciente específica del hipertiroidismo en Cuba.  Material y Métodos:  Se revisó y adaptó el modelo genérico de Medicina Nuclear paciente específica. Con el código cubano SECURE MR-FMEA versión 3.0 se determinaron el riesgo inherente y el residual, se identificaron las etapas del proceso, los sucesos iniciadores, las medidas y causas más contribuyentes, así como las consecuencias para los grupos expuestos.  Resultados: Se obtuvo un nivel alto de riesgo que se controló con las medidas adicionadas. Las etapas más significativas son: la adquisición de imágenes pre- y post- tratamiento y la preparación del radiofármaco. Las medidas preventivas más importantes son: mantener una carga de trabajo moderada para el personal, las capacitaciones del físico médico y de los especialistas que realizan las revisiones del proyecto en la etapa de diseño del servicio. Los pacientes tienen consecuencias muy altas en 10,7 % de las secuencias accidentales. Sin embargo, los trabajadores y el público presentan consecuencias medias en 29 % y 16 %, respectivamente. El incumplimiento de prácticas, protocolos, procedimientos o normas es la causa básica de fallo predominante.  Conclusiones: Se facilita la toma de decisiones para la implementación del tratamiento paciente específico del hipertiroidismo en Cuba, a partir del empleo de la metodología que se propone en esta investigación.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  In Cuba, there are plans to conduct patient-specific therapy for hyperthyroidism. A methodology and computational tools have been developed for this purpose. Risk analysis will allow us to undertake this practice with quality and safety.  Objective: To analyze the radiological risks in the patient -specific therapy for hyperthyroidism in Cuba.  Material and Methods: The generic patient-specific Nuclear Medicine model was reviewed and adapted. Inherent and residual risk were determined with the Cuban code SECURE MR-FMEA version 3.0; the stages of the process, the initiating events, the most contributing measures and causes, and the consequences for the exposed groups were identified.  Results: A high level of risk was obtained, which was controlled with additional measures. The most significant stages are the acquisition of pre- and post-treatment images, and the preparation of the radiopharmaceutical. The most important preventive measures are: maintaining a moderate workload of the staff, and the training of the medical physicist and the specialists who perform the project reviews at the stages in service design. Patients have very high consequences in 10,7 % of accidental sequences. However, the workers and the public show average consequences at 29 % and 16 %, respectively. Non-compliance with practices, protocols, procedures or standards is the predominant underlying cause of failure.  Conclusions: Decision-making for the implementation of patient-specific therapy for hyperthyroidism in Cuba, based on the use of the methodology proposed in this research, is facilitated.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[riesgos por radiación]]></kwd>
<kwd lng="es"><![CDATA[terapia paciente específica, hipertiroidismo, matriz de riesgo, análisis de modos y efectos de fallo]]></kwd>
<kwd lng="en"><![CDATA[Radiation risks]]></kwd>
<kwd lng="en"><![CDATA[patient-specific therapy, hyperthyroidism, risk matrix, failure modes and effects analysis]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martín Vélez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado Martín]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez López]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Soto Blanco]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez López]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Maldonado Díaz]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Un paciente con hipertiroidismo]]></article-title>
<source><![CDATA[Medicina Integral]]></source>
<year>2001</year>
<volume>37</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>383-9</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López Díaz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Reynosa]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Palau]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Martín]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Castillo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Calibración de cámaras gamma para optimización del tratamiento con 131I en hipertiroidismo]]></source>
<year>2015</year>
<conf-name><![CDATA[ X Congreso Regional Latinoamericano IRPA de Protección y Seguridad Radiológica "Radioprotección: Nuevos Desafíos para un Mundo en Evolución"]]></conf-name>
<conf-date>2015 abril 12-17</conf-date>
<conf-loc>Buenos Aires, Argentina </conf-loc>
<publisher-loc><![CDATA[Buenos Aires ]]></publisher-loc>
<publisher-name><![CDATA[Sociedad Argentina de Radioprotección]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hyer]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pratt]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Gray]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chittenden]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Duc]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Harmer]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dosimetry-based treatment for Graves' disease]]></article-title>
<source><![CDATA[Nuclear Medicine Communications]]></source>
<year>2018</year>
<volume>39</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>486-92</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fanning]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Inder]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Mackenzie]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Radioiodine treatment for graves' disease: a 10-year Australian cohort study]]></article-title>
<source><![CDATA[BMC Endocrine Disorders]]></source>
<year>2018</year>
<volume>18</volume>
<numero>94</numero>
<issue>94</issue>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khalili]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Miri Hakimabada]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hoseinian Azghadi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patient-specific anatomical models for radioiodine dosimetry in treatment of hyperthyroidism: is it necessary?]]></article-title>
<source><![CDATA[Medical Physic]]></source>
<year>2020</year>
<volume>47</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>5357-65</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alfonso Laguardia]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[López Díaz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz Rizo]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La física médica en la ciudad de La Habana]]></article-title>
<source><![CDATA[Nucleus]]></source>
<year>2019</year>
<volume>66</volume>
<page-range>52</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López Díaz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Reynosa Montejo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obtención combinada de parámetros para la planificación dosimétrica 2D y 3D de tratamientos con 131I en Hipertiroidismo]]></article-title>
<collab>Palau San Pedro A.Martín Escuela J.Torres Aroche L</collab>
<source><![CDATA[Nucleus]]></source>
<year>2017</year>
<volume>61</volume>
<page-range>16-20</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López Díaz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Martín]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos Rodríguez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimación de las desviaciones volumétricas de dosis entregada vs planificada durante el tratamiento de hipertiroidismo con 131I: resultados preliminares]]></article-title>
<source><![CDATA[Nucleus]]></source>
<year>2019</year>
<volume>65</volume>
<page-range>1-5</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<collab>Ministerio de Ciencia Tecnología y Medio Ambiente</collab>
<source><![CDATA[Reglamento sobre Notificación y Autorización de Prácticas y Actividades Asociadas al Empleo de Fuentes de Radiaciones Ionizantes]]></source>
<year>2012</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Ciencia Tecnología y Medio Ambiente]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<collab>Centro Nacional de Seguridad Nuclear</collab>
<source><![CDATA[Guía de Evaluación de Seguridad de Prácticas y Actividades Asociadas al Empleo de Fuentes de Radiaciones Ionizantes]]></source>
<year>2012</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Centro Nacional de Seguridad Nuclear]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amador Balbona]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Torres Valle]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis de Riesgo Radiológico en Medicina Nuclear Terapéutica Paciente Específico]]></article-title>
<source><![CDATA[J Health Med Sci]]></source>
<year>2018</year>
<volume>4</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>215-23</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torres Valle]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Manual de Usuario SECURE-MR-FMEA 3.0, Programa de análisis de riesgo basado en matriz de riesgo y FMEA]]></source>
<year>2017</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Centro Nacional de Seguridad Nuclear]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amador Balbona]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Torres Valle]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Conversión de matriz de riesgo a análisis de modos y efectos de fallos]]></article-title>
<source><![CDATA[Revista Cubana de Salud y Trabajo]]></source>
<year>2019</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>3-10</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amador Balbona]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Torres Valle]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Causas básicas de fallos aplicadas al análisis de riesgo en práctica médicas con radiaciones ionizantes]]></article-title>
<source><![CDATA[Revista Cubana de Salud y Trabajo]]></source>
<year>2019</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>11-8</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Da Silva Teixeira]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[De Almeida]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Saiful Huq]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Failure mode and effect analysis based risk pro?le assessment for stereotactic radiosurgery programs at three cancer centers in Brazil]]></article-title>
<source><![CDATA[Medical Physic]]></source>
<year>2016</year>
<volume>43</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>171-8</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gutiérrez Pulido]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Calidad total y productividad]]></source>
<year>2010</year>
<edition>3</edition>
<publisher-loc><![CDATA[EE UU ]]></publisher-loc>
<publisher-name><![CDATA[McGraw-Hill/Interamericana]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<collab>Organismo Internacional de Energía Atómica, Foro Iberoamericano de Organismos Reguladores en Seguridad Nuclear, Radiológica y Física</collab>
<source><![CDATA[Aplicación de la matriz de riesgo a la radioterapia. IAEA-TECDOC 1685/S]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Austria ]]></publisher-loc>
<publisher-name><![CDATA[Organismo Internacional de Energía Atómica]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duménigo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[López Morones]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Papadópulos]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[McDonnell]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Morales López]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Metodología de matrices de riesgo. Actualización de la misma basada en las experiencias en su aplicación]]></source>
<year>2018</year>
<conf-name><![CDATA[ XI Congreso Regional de Seguridad Radiológica y Nuclear Congreso Regional IRPA "Cultura de Seguridad: un compromiso compartido"]]></conf-name>
<conf-date>2018 abril 16-20</conf-date>
<conf-loc>La Habana, Cuba </conf-loc>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Centro Nacional de Seguridad Nuclear]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<collab>The Australian Radiation Incident Register</collab>
<source><![CDATA[Radiation protection]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Australia ]]></publisher-loc>
<publisher-name><![CDATA[ARPANSA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="book">
<collab>Nuclear Regulatory Commission United States</collab>
<source><![CDATA[]]></source>
<year>2019</year>
<publisher-loc><![CDATA[United States ]]></publisher-loc>
<publisher-name><![CDATA[NRC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<collab>International Atomic Energy Agency</collab>
<source><![CDATA[Safety in Radiation Oncology, SAFRON]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Austria ]]></publisher-loc>
<publisher-name><![CDATA[IAEA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="book">
<collab>Centro Nacional de Seguridad Nuclear</collab>
<source><![CDATA[Guía Expectativas del Organismo Regulador sobre la Cultura de Seguridad en las Organizaciones que Realizan Actividades con Fuentes de Radiación Ionizante]]></source>
<year>2015</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[CNSN]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López Morones]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Duménigo González]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Espinosa S]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Papadopulos]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Joana]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Overview of Risk Models and Results Obtained by Foro Project (SEVRRA 2) for IMRT and DNM Techniques]]></source>
<year>2020</year>
<conf-name><![CDATA[ International Conference on Radiation Safety: Improving Radiation Protection in Practice]]></conf-name>
<conf-date>2020 Sep 09-20</conf-date>
<conf-loc> </conf-loc>
<publisher-loc><![CDATA[Austria ]]></publisher-loc>
<publisher-name><![CDATA[IAEA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bhatnagar]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bednarz]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Flickinger]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Arai]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Vacsulka]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Failure modes and effects analysis (FMEA) for Gamma knife radiosurgery]]></article-title>
<source><![CDATA[J Appl Clin Med Phys]]></source>
<year>2017</year>
<volume>18</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>152-68</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herrera]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Arciniegas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resultados e interpretación al aplicar la técnica de matriz de riesgo en braquiterapia]]></article-title>
<source><![CDATA[Revista Investigaciones y Aplicaciones Nucleares]]></source>
<year>2019</year>
<volume>3</volume>
<page-range>5-11</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Darrar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mahmoud]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ezzel Din]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Khalaf]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mostafa]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk assessment for occupational potential exposure at cobalt teletherapy units]]></article-title>
<source><![CDATA[Journal of Radiation Research And Applied Sciences]]></source>
<year>2019</year>
<volume>12</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>140-6</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saiful Huq]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fraass]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Dunscombe]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gibbons]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ibbott]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Mundt]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management]]></article-title>
<source><![CDATA[Med Phys]]></source>
<year>2016</year>
<volume>43</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>4209-62</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
